Elana Simon '14 Shares the Stage with President Obama
Today Elana Simon (Dalton, Class of 2014, Harvard, Class of 2018), a fibrolamellar patient/researcher and member of the Fibrolamellar Registry board, headed to the White House to stand on stage as President Obama signed the 21 Century Cures Act.
This past week the US House and Senate passed the 21st Century Cures Act. This provides $5 billion for the NIH for The Precision Medicine Initiative, Brain Initiative and the Moonshot on Cancer -- a legislation established earlier this year aiming to make therapies more available and improving early stage prevention. Its emphasis was given to pediatric, adolescent and young adult cancers, including fibrolamellar.